Carotid endarterectomy - An evidence-based review: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

S. Chaturvedi, Askiel Bruno, T. Feasby, R. Holloway, O. Benavente, S. N. Cohen, R. Cote, David C Hess, J. Saver, J. D. Spence, B. Stern, J. Wilterdink

Research output: Contribution to journalArticle

Abstract

Objective: To assess the efficacy of carotid endarterectomy for stroke prevention in asymptomatic and symptomatic patients with internal carotid artery stenosis. Additional clinical scenarios, such as use of endarterectomy combined with cardiac surgery, are also reviewed. Methods: The authors selected nine important clinical questions. A systematic search was performed for articles from 1990 (the year of the last statement) until 2001. Additional articles from 2002 through 2004 were included using prespecified criteria. Two reviewers also screened for other relevant articles from 2002 to 2004. Case reports, review articles, technical studies, and single surgeon case series were excluded. Results: For several questions, high quality randomized clinical trials had been completed. Carotid endarterectomy reduces the stroke risk compared to medical therapy alone for patients with 70 to 99% symptomatic stenosis (16% absolute risk reduction at 5 years). There is a smaller benefit for patients with 50 to 69% symptomatic stenosis (absolute risk reduction 4.6% at 5 years). There is a small benefit for asymptomatic patients with 60 to 99% stenosis if the perioperative complication rate is low. Aspirin in a dose of 81 to 325 mg per day is preferred vs higher doses (650 to 1,300 mg per day) in patients undergoing endarterectomy. Conclusions: Evidence supports carotid endarterectomy for severe (70 to 99%) symptomatic stenosis (Level A). Endarterectomy is moderately useful for symptomatic patients with 50 to 69% stenosis (Level B) and not indicated for symptomatic patients with <50% stenosis (Level A). For asymptomatic patients with 60 to 99% stenosis, the benefit/risk ratio is smaller compared to symptomatic patients and individual decisions must be made. Endarterectomy can reduce the future stroke rate if the perioperative stroke/death rate is kept low (<3%) (Level A). Low dose aspirin (81 to 325 mg) is preferred for patients before and after carotid endarterectomy to reduce the rate of stroke, myocardial infarction, and death (Level A).

Original languageEnglish (US)
Pages (from-to)197-204
Number of pages8
JournalCONTINUUM Lifelong Learning in Neurology
Volume14
Issue number1
DOIs
StatePublished - Feb 1 2008

Fingerprint

Biomedical Technology Assessment
Carotid Endarterectomy
Pathologic Constriction
Endarterectomy
Stroke
Therapeutics
Numbers Needed To Treat
Aspirin
Carotid Stenosis
Thoracic Surgery
Randomized Controlled Trials
Odds Ratio
Myocardial Infarction

ASJC Scopus subject areas

  • Clinical Neurology
  • Genetics(clinical)

Cite this

Carotid endarterectomy - An evidence-based review : Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. / Chaturvedi, S.; Bruno, Askiel; Feasby, T.; Holloway, R.; Benavente, O.; Cohen, S. N.; Cote, R.; Hess, David C; Saver, J.; Spence, J. D.; Stern, B.; Wilterdink, J.

In: CONTINUUM Lifelong Learning in Neurology, Vol. 14, No. 1, 01.02.2008, p. 197-204.

Research output: Contribution to journalArticle

Chaturvedi, S. ; Bruno, Askiel ; Feasby, T. ; Holloway, R. ; Benavente, O. ; Cohen, S. N. ; Cote, R. ; Hess, David C ; Saver, J. ; Spence, J. D. ; Stern, B. ; Wilterdink, J. / Carotid endarterectomy - An evidence-based review : Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. In: CONTINUUM Lifelong Learning in Neurology. 2008 ; Vol. 14, No. 1. pp. 197-204.
@article{de82973317574809970aa73070d8a872,
title = "Carotid endarterectomy - An evidence-based review: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology",
abstract = "Objective: To assess the efficacy of carotid endarterectomy for stroke prevention in asymptomatic and symptomatic patients with internal carotid artery stenosis. Additional clinical scenarios, such as use of endarterectomy combined with cardiac surgery, are also reviewed. Methods: The authors selected nine important clinical questions. A systematic search was performed for articles from 1990 (the year of the last statement) until 2001. Additional articles from 2002 through 2004 were included using prespecified criteria. Two reviewers also screened for other relevant articles from 2002 to 2004. Case reports, review articles, technical studies, and single surgeon case series were excluded. Results: For several questions, high quality randomized clinical trials had been completed. Carotid endarterectomy reduces the stroke risk compared to medical therapy alone for patients with 70 to 99{\%} symptomatic stenosis (16{\%} absolute risk reduction at 5 years). There is a smaller benefit for patients with 50 to 69{\%} symptomatic stenosis (absolute risk reduction 4.6{\%} at 5 years). There is a small benefit for asymptomatic patients with 60 to 99{\%} stenosis if the perioperative complication rate is low. Aspirin in a dose of 81 to 325 mg per day is preferred vs higher doses (650 to 1,300 mg per day) in patients undergoing endarterectomy. Conclusions: Evidence supports carotid endarterectomy for severe (70 to 99{\%}) symptomatic stenosis (Level A). Endarterectomy is moderately useful for symptomatic patients with 50 to 69{\%} stenosis (Level B) and not indicated for symptomatic patients with <50{\%} stenosis (Level A). For asymptomatic patients with 60 to 99{\%} stenosis, the benefit/risk ratio is smaller compared to symptomatic patients and individual decisions must be made. Endarterectomy can reduce the future stroke rate if the perioperative stroke/death rate is kept low (<3{\%}) (Level A). Low dose aspirin (81 to 325 mg) is preferred for patients before and after carotid endarterectomy to reduce the rate of stroke, myocardial infarction, and death (Level A).",
author = "S. Chaturvedi and Askiel Bruno and T. Feasby and R. Holloway and O. Benavente and Cohen, {S. N.} and R. Cote and Hess, {David C} and J. Saver and Spence, {J. D.} and B. Stern and J. Wilterdink",
year = "2008",
month = "2",
day = "1",
doi = "10.1212/01.CON.0000299984.86576.03",
language = "English (US)",
volume = "14",
pages = "197--204",
journal = "CONTINUUM Lifelong Learning in Neurology",
issn = "1080-2371",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Carotid endarterectomy - An evidence-based review

T2 - Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

AU - Chaturvedi, S.

AU - Bruno, Askiel

AU - Feasby, T.

AU - Holloway, R.

AU - Benavente, O.

AU - Cohen, S. N.

AU - Cote, R.

AU - Hess, David C

AU - Saver, J.

AU - Spence, J. D.

AU - Stern, B.

AU - Wilterdink, J.

PY - 2008/2/1

Y1 - 2008/2/1

N2 - Objective: To assess the efficacy of carotid endarterectomy for stroke prevention in asymptomatic and symptomatic patients with internal carotid artery stenosis. Additional clinical scenarios, such as use of endarterectomy combined with cardiac surgery, are also reviewed. Methods: The authors selected nine important clinical questions. A systematic search was performed for articles from 1990 (the year of the last statement) until 2001. Additional articles from 2002 through 2004 were included using prespecified criteria. Two reviewers also screened for other relevant articles from 2002 to 2004. Case reports, review articles, technical studies, and single surgeon case series were excluded. Results: For several questions, high quality randomized clinical trials had been completed. Carotid endarterectomy reduces the stroke risk compared to medical therapy alone for patients with 70 to 99% symptomatic stenosis (16% absolute risk reduction at 5 years). There is a smaller benefit for patients with 50 to 69% symptomatic stenosis (absolute risk reduction 4.6% at 5 years). There is a small benefit for asymptomatic patients with 60 to 99% stenosis if the perioperative complication rate is low. Aspirin in a dose of 81 to 325 mg per day is preferred vs higher doses (650 to 1,300 mg per day) in patients undergoing endarterectomy. Conclusions: Evidence supports carotid endarterectomy for severe (70 to 99%) symptomatic stenosis (Level A). Endarterectomy is moderately useful for symptomatic patients with 50 to 69% stenosis (Level B) and not indicated for symptomatic patients with <50% stenosis (Level A). For asymptomatic patients with 60 to 99% stenosis, the benefit/risk ratio is smaller compared to symptomatic patients and individual decisions must be made. Endarterectomy can reduce the future stroke rate if the perioperative stroke/death rate is kept low (<3%) (Level A). Low dose aspirin (81 to 325 mg) is preferred for patients before and after carotid endarterectomy to reduce the rate of stroke, myocardial infarction, and death (Level A).

AB - Objective: To assess the efficacy of carotid endarterectomy for stroke prevention in asymptomatic and symptomatic patients with internal carotid artery stenosis. Additional clinical scenarios, such as use of endarterectomy combined with cardiac surgery, are also reviewed. Methods: The authors selected nine important clinical questions. A systematic search was performed for articles from 1990 (the year of the last statement) until 2001. Additional articles from 2002 through 2004 were included using prespecified criteria. Two reviewers also screened for other relevant articles from 2002 to 2004. Case reports, review articles, technical studies, and single surgeon case series were excluded. Results: For several questions, high quality randomized clinical trials had been completed. Carotid endarterectomy reduces the stroke risk compared to medical therapy alone for patients with 70 to 99% symptomatic stenosis (16% absolute risk reduction at 5 years). There is a smaller benefit for patients with 50 to 69% symptomatic stenosis (absolute risk reduction 4.6% at 5 years). There is a small benefit for asymptomatic patients with 60 to 99% stenosis if the perioperative complication rate is low. Aspirin in a dose of 81 to 325 mg per day is preferred vs higher doses (650 to 1,300 mg per day) in patients undergoing endarterectomy. Conclusions: Evidence supports carotid endarterectomy for severe (70 to 99%) symptomatic stenosis (Level A). Endarterectomy is moderately useful for symptomatic patients with 50 to 69% stenosis (Level B) and not indicated for symptomatic patients with <50% stenosis (Level A). For asymptomatic patients with 60 to 99% stenosis, the benefit/risk ratio is smaller compared to symptomatic patients and individual decisions must be made. Endarterectomy can reduce the future stroke rate if the perioperative stroke/death rate is kept low (<3%) (Level A). Low dose aspirin (81 to 325 mg) is preferred for patients before and after carotid endarterectomy to reduce the rate of stroke, myocardial infarction, and death (Level A).

UR - http://www.scopus.com/inward/record.url?scp=40049086047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40049086047&partnerID=8YFLogxK

U2 - 10.1212/01.CON.0000299984.86576.03

DO - 10.1212/01.CON.0000299984.86576.03

M3 - Article

AN - SCOPUS:40049086047

VL - 14

SP - 197

EP - 204

JO - CONTINUUM Lifelong Learning in Neurology

JF - CONTINUUM Lifelong Learning in Neurology

SN - 1080-2371

IS - 1

ER -